Clinical area: Cardiovascular - Digital health technologies for patients in the community with heart failure, high blood pressure, cardiac arrhythmia or awaiting definitive cardiac interventions to guide treatment and signal any early signs of clinical deterioration

Why:

• Cardiovascular disease (CVD) is one of the main causes of death and disability in the UK, but it can often largely be prevented by leading a healthy lifestyle.
• The most important behavioural risk factors of heart disease and stroke are unhealthy diet, physical inactivity, tobacco use and harmful use of alcohol. Amongst environmental risk factors, air pollution is an important factor.
• The effects of behavioural risk factors may show up in individuals as raised blood pressure, raised blood glucose, raised blood lipids, and overweight and obesity.

Products in scope:

Digital health technologies should meet the following criteria:

• Are intended for use by people of all age ranges in a community setting
• Are intended for use by people with; heart failure, high blood pressure, cardiac arrhythmia or awaiting definitive cardiac interventions to guide treatment and signal any early signs of clinical deterioration.
• Meet the standards within the digital technology assessment criteria (DTAC), including the criteria to have a CE or UKCA mark where required.
• Products may also be considered if they are actively working towards required CE or UKCA mark, have been deployed in a small number (2-10) of NHS sites or comparable clinical providers internationally.

If your product is in development, the NHS Innovation Service can help support you meet these standards and other requirements.

Further information:

If you have an innovation that meets that need, create an NHS Innovation Service account and fill in your innovation record to start receiving support for this innovation.